Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: Risk factors for accelerated macrovascular damage?

Clinical Reviews in Allergy and Immunology

Volumn 36, Issue 2-3, 2009, Pages 145-149

  Szamosi, Szilvia ^a   Csiki, Zoltán ^a   Szomják, Edit ^a   Szolnoki, Erzsébet ^a   Szőke, Gabriella ^a   Szekanecz, Zoltán ^a   Szegedi, Gyula ^b   Shoenfeld, Yehuda ^c   Szucs, Gabriella ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Folate; Homocysteine; Systemic sclerosis; Vascular disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PREVALENCE; PULMONARY HYPERTENSION; RISK FACTOR; SYSTEMIC SCLEROSIS; THROMBOEMBOLISM; VASCULAR DISEASE; BLOOD; GENETIC PREDISPOSITION; GENETICS; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOLOGY; LUNG FIBROSIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TIME;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; HYPERTROPHY, RIGHT VENTRICULAR; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY FIBROSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC; THROMBOEMBOLISM; TIME FACTORS;

EID: 66349134773     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-008-8105-y     Document Type: Article

References (26)

1. HN Claman RC Giorno JR Seibold 1991 Endothelial and fibroblastic activation in scleroderma: the myth of the "uninvolved" skin Arthritis Rheum 34 1495 1501
2. M Ho DJ Veale C Eastmond G Nuki J Belch 2000 Macrovascular disease in systemic sclerosis Ann Rheum Dis 59 39 43
3. DL Harmon JV Woodside JW Yarnel D McMaster IS Yuong EE McCrum et al. 1996 The common thermolabile variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia Q J Med 89 571 7
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma) 1980 Subcommittee for scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthitis Rheum 23 581 90
5. EC LeRoy C Black R Fleischmajer S Jablonska T Krieg TA Medsger Jr et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205
6. JB Ubbink WJ Hayward Vermaak S Bissbort 1991 Rapid HPLC assay for total homocysteine levels in human serum J Chromatogr 565 441 446
7. E Gillian MD Gibson L Hongzhe R Mark MD Pittelkow 1999 Homocysteinaemia and livedoid vasculitis J Am Acad Dermatol 40 279 281
8. M Usui H Matsuoka H Miyazaki S Ueda S Okuda T Imaizumi 1999 Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoriation by folic acid Clin Science 96 235 239
9. FGR Fowkes AJ Lee CM Hau A Cooke JM Connor GDO Lowe 2000 Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study Atherosclerosis 150 179 185
10. J Ma MJ Stampfer CH Hennekens P Frosst J Selhub J Horsford et al. 1996 Methylenetetrahydrofolate reductase: polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians Circulation 94 2410 2416
11. LAJ Kluijtmans M Den Heijer PH Reitsma SG Heil HJ Blom ER Rosendaal 1998 Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis Thromb Haemost 79 254 258
12. A Mathieu A Cauli MT Fiorillo R Sorrentino 2008 HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis Autoimmun Rev 7 398 403
13. J Castro E Balada J Ordi-Ros M Vilardell-Tarres 2008 The complex immunogenetic basis of systemic lupus erythematosus Autoimmun Rev 7 345 351
14. C Daridon P Youinou JO Pers 2008 BAFF, APRIL, TWE-PRIL: who's who? Autoimmun Rev 7 267 271
15. K Ozawa K Sato I Oh K Ozaki R Uchibori Y Obara et al. 2008 Cell and gene therapy using mesenchymal stem cells (MSCs) J Autoimmun 30 121 127
16. PL Meroni 2008 Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity J Autoimun 30 99 103
17. IR Mackay NV Leskovsek NR Rose 2008 Cell damage and autoimmunity: a critical appraisal J Autoimmun 30 5 11
18. HS Li DL Ligons NR Rose 2008 Genetic complexity of autoimmune myocarditis Autoimmun Rev 7 168 173
19. EM Jacobson A Huber Y Tomer 2008 The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology J Autoimmun 30 58 62
20. Z Husain MA Kelly GS Eisenbarth A Pugliese ZL Awdeh CE Larsen et al. 2008 The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1 J Autoimmun 30 266 272
21. S Sodin-Semrl B Rozman 2007 Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels Autoimmun Rev 6 547 552
22. LE Wrenshall DR Smith ET Stevens JD Miller 2007 Influence of interleukin-2 deficiency on the generation of autoimmune B cells J Autoimmun 29 125 133
23. M Mahler R Raijmakers 2007 Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights Autoimmun Rev 6 432 437
24. MA Khan A Mathieu R Sorrentino N Akkoc 2007 The pathogenetic role of HLA-B27 and its subtypes Autoimmun Rev 6 183 189
25. CJ Ross H Katzov B Carleton MR Hayden 2007 Pharmacogenomics and its implications for autoimmune disease J Autoimmun 28 133 138
26. K Shternhall-Ron FJ Quintana S Perl J Meivar-Levy I Barshack IR Cohen et al. 2007 Ectopic PDX-1 expression in liver ameliorates type 1 diabetes J Autoimmun 28 134 142